Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Schizophrenia News

News
Paliperidone Palmitate May Delay First Major Treatment Failure in Recent-Onset Schizophrenia
09/26/2022
Jolynn Tumolo
Major treatment failure occurred at a lower rate in patients with recent-onset schizophrenia or schizophreniform disorder treated with the long-acting injectable (LAI) antipsychotic paliperidone palmitate (PP) compared with oral...
Major treatment failure occurred at a lower rate in patients with recent-onset schizophrenia or schizophreniform disorder treated with the long-acting injectable (LAI) antipsychotic paliperidone palmitate (PP) compared with oral...
Major treatment failure occurred...
09/26/2022
Psych Congress Network
News
Targeting Anhedonia May Help Functioning in Patients With Schizophrenia
09/14/2022
Jolynn Tumolo
Anhedonia appears to be a rational treatment target for improving global functioning in patients with schizophrenia, suggest study findings published online ahead of print in JAMA Psychiatry.
Anhedonia appears to be a rational treatment target for improving global functioning in patients with schizophrenia, suggest study findings published online ahead of print in JAMA Psychiatry.
Anhedonia appears to be a...
09/14/2022
Psych Congress Network
News
Severe Mental Illness Linked with Higher Odds of Multiple Chronic Conditions
09/13/2022
Jolynn Tumolo
People with severe mental illness have elevated odds for a range of chronic physical health problems 5 years before through 5 years after their diagnosis of schizophrenia, bipolar disorder, or other psychotic illness, according to a study...
People with severe mental illness have elevated odds for a range of chronic physical health problems 5 years before through 5 years after their diagnosis of schizophrenia, bipolar disorder, or other psychotic illness, according to a study...
People with severe mental...
09/13/2022
Psych Congress Network

Advertisement

News
Earlier Clozapine Offers Long-Term Benefit in Treatment-Resistant Schizophrenia
08/10/2022
Jolynn Tumolo
Patients with treatment-resistant schizophrenia who started clozapine earlier had significantly better Clinical Global Impression (CGI) scores at a 10-year follow-up than patients who waited the longest to start the drug.
Patients with treatment-resistant schizophrenia who started clozapine earlier had significantly better Clinical Global Impression (CGI) scores at a 10-year follow-up than patients who waited the longest to start the drug.
Patients with...
08/10/2022
Psych Congress Network
News
Scant Differences in Schizophrenia Relapse Between Antipsychotics, Meta-analysis Finds
04/20/2022
Jolynn Tumolo
When it comes to antipsychotic selection for the maintenance treatment of patients with schizophrenia, tolerability may be the best guide, advised authors of a systematic review and network meta-analysis.
When it comes to antipsychotic selection for the maintenance treatment of patients with schizophrenia, tolerability may be the best guide, advised authors of a systematic review and network meta-analysis.
When it comes to antipsychotic...
04/20/2022
Psych Congress Network
News
FDA Approves Dissolving Sublingual Film for Agitation in Schizophrenia, Bipolar I or II
04/06/2022
Meagan Thistle
The FDA has approved IGALMI™ (dexmedetomidine), a dissolving sublingual film, for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
The FDA has approved IGALMI™ (dexmedetomidine), a dissolving sublingual film, for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
The FDA has approved IGALMI™...
04/06/2022
Psych Congress Network

Advertisement

News
Interactive Report: Aripiprazole LAI Effective in Treating Schizophrenia in Adolescent
02/24/2022
Meagan Thistle
A 2-injection start regimen of aripiprazole LAI showed good efficacy and tolerability in a 16-year-old adolescent with schizophrenia, according to a recent case report.
A 2-injection start regimen of aripiprazole LAI showed good efficacy and tolerability in a 16-year-old adolescent with schizophrenia, according to a recent case report.
A 2-injection start regimen of...
02/24/2022
Psych Congress Network
News
Risk of COVID-19 Death Nearly 4 Times Higher in People with Schizophrenia
01/06/2022
Jolynn Tumolo
People with schizophrenia had higher odds of dying from COVID-19 but had significantly lower rates of testing positive for COVID-19 compared with the general population.
People with schizophrenia had higher odds of dying from COVID-19 but had significantly lower rates of testing positive for COVID-19 compared with the general population.
People with schizophrenia had...
01/06/2022
Psych Congress Network
News
Abnormal Pattern of Emotional Regulation Identified in People With Schizophrenia
12/13/2021
Jolynn Tumolo
Patients with schizophrenia tend to regulate low-level negative emotions too much and high-level negative emotions too little, according to new study findings.
Patients with schizophrenia tend to regulate low-level negative emotions too much and high-level negative emotions too little, according to new study findings.
Patients with schizophrenia tend...
12/13/2021
Psych Congress Network

Advertisement

News
Combined Intervention Shows Promise for Easing Negative Symptoms of Psychosis
12/01/2021
Jolynn Tumolo
New research shows an intervention combining CBSST-CCT improved negative symptoms and verbal learning in adults with schizophrenia.
New research shows an intervention combining CBSST-CCT improved negative symptoms and verbal learning in adults with schizophrenia.
New research shows an...
12/01/2021
Psych Congress Network

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use